Background The goal of this prospective study was to compare the value of both
conventional MRI and O-(2-18 F-fluoroethyl)-L-tyrosine (FET) PET for response evaluation in …

Purpose To investigate prospectively the potential of O-(2-[18 F] fluoroethyl)-l-tyrosine (18 F-
FET) PET in comparison to MRI for the assessment of the response of patients with recurrent …

Purpose Normalization of tumor vasculature after administering bevacizumab (BEV) makes
assessment of therapeutic response using MRI difficult. The aim of this study was to clarify …

Purpose: This study compares the value of 3, 4-dihydroxy-6-[18F]-fluoro-l-phenylalanine
(18F-FDOPA) positron emission tomography (PET) and MRI in assessing outcome during …

The goal of this study was to compare the value of contrast-enhanced MRI and O-(2-[18F]
fluoroethyl)-l-tyrosine (18F-FET) PET for response assessment in glioma patients after …

Purpose In this study, we investigated fluorine-18 fluoromethylcholine (18 F-FCho) PET and
contrast-enhanced MRI for predicting therapy response in glioblastoma (GB) patients …

Background Glioblastoma patients show a great variability in progression free survival (PFS)
and overall survival (OS). To gain additional pretherapeutic information, we explored the …

The individualized care of glioma patients ought to benefit from imaging biomarkers as
precocious predictors of therapeutic efficacy. Contrast enhanced MRI and [18F] …

Background The objective of this study was to evaluate the potential of integrated 11C-MET
PET/MR for response assessment of relapsed glioblastoma (GBM) receiving bevacizumab …

The objective of this study was to compare MRI response assessment with metabolic O-(2-
18F-fluoroethyl)-l-tyrosine (18F-FET) PET response evaluation during antiangiogenic …